[Effect of thyroid hormones on calcitonin secretion]

Area of Science:

• Endocrinology
• Thyroid Research
• Calcium Metabolism

Background:

• Diffuse toxic goiter (Graves' disease) involves hyperthyroidism and potential alterations in thyroid hormone and calcitonin dynamics.
• Calcitonin, a thyroid hormone, plays a role in calcium regulation, and its secretion patterns in hyperthyroid states require further elucidation.

Purpose of the Study:

• To investigate the dynamic changes in plasma calcitonin concentration and activity during the progression of diffuse toxic goiter.
• To assess the basal calcitonin secretion of thyroid tissue from patients with goiter and thyrotoxicosis.
• To evaluate the effect of thyroxin on calcitonin secretion in different stages of thyroid disease.

Main Methods:

• Analysis of plasma calcitonin concentration and blood calcitonin activity in 140 patients with diffuse toxic goiter.
• In vitro incubation of thyroid tissue fragments from patients with nodular euthyroid goiter and thyrotoxicosis with varying thyroxin concentrations.
• Comparison of basal calcitonin secretion between euthyroid and thyrotoxic thyroid tissue.

Main Results:

• Plasma calcitonin levels initially increased in early diffuse toxic goiter, then decreased in severe thyrotoxicosis.
• Basal calcitonin secretion was significantly higher in thyrotoxic thyroid tissue compared to euthyroid tissue.
• Thyroxin at 10(-8) M stimulated calcitonin secretion in moderate thyrotoxicosis and nodular goiter, but not in severe thyrotoxicosis.
• Thyroid tissue from severe diffuse toxic goiter showed non-reactivity to thyroxin stimulation.

Conclusions:

• Calcitonin secretion exhibits a biphasic pattern in diffuse toxic goiter, correlating with disease severity.
• Thyroxin acts as a calcitonin secretion stimulator, with efficacy dependent on disease stage.
• Evidence suggests depletion of the thyroid's calcitonin-producing capacity in advanced diffuse toxic goiter.